Logo Hlth
29 May 2025

Ciba Health and ADA Join Forces to Transform Chronic Care

Ciba Health, a digital health platform specializing in personalized, outcomes-based care for chronic conditions, has announced a strategic collaboration with the American Diabetes Association (ADA) to transform prevention and treatment strategies for type 2 diabetes. The partnership represents a significant step forward in addressing the diabetes epidemic through the integration of innovative digital health solutions and established advocacy infrastructure.

The collaboration brings together Ciba Health's root-cause medical approach with the ADA's national leadership in advocacy, research, and public education. This strategic alignment aims to advance chronic disease prevention and management by sharing evidence-based tools and insights, while empowering communities through targeted education for individuals, families, and healthcare professionals. Additionally, the partnership seeks to improve health access by addressing care disparities and expanding the availability of personalized interventions.

The urgency of this collaboration is underscored by the ADA's estimate that over 136 million Americans currently live with diabetes or prediabetes. This staggering figure highlights the critical need for a paradigm shift from reactive care models to preventative, personalized approaches that address the underlying causes of chronic disease.

Brandi Williams Broome, Chief Development and Delivery Officer at the ADA, emphasized the transformative potential of scalable community-based interventions in reducing type 2 diabetes prevalence. The partnership leverages both organizations' strengths to create comprehensive solutions that can reach diverse populations and deliver meaningful health outcomes.

Ciba Health's care model represents a comprehensive approach to chronic disease management, integrating multidisciplinary medical teams with advanced diagnostic capabilities. The platform utilizes lab diagnostics covering up to 300 biomarkers, wearable health technology, and continuous nutrition and lifestyle coaching. This holistic approach has already demonstrated measurable success in enterprise settings, achieving significant reductions in A1C levels and sustained weight loss among participants.

"While diabetes affects one in ten Americans, type 2 diabetes is often preventable," noted Dr. Innocent Clement, CEO and Founder of Ciba Health. He emphasized the critical importance of shifting focus from symptom management to addressing underlying causes through data-informed, patient-centered strategies.

The partnership builds upon Ciba Health's recent achievements, including a $10 million oversubscribed Series A funding round and the launch of Thrive by Ciba Health, a data-powered platform designed to optimize health and longevity. The company has also received validation from the Validation Institute for its value-based care model, affirming the effectiveness of its approach to chronic disease management.

Looking ahead, Ciba Health plans to pursue additional collaborations aimed at improving population health outcomes. The company continues to expand its digital care ecosystem with the ambitious goal of reversing and preventing complex chronic conditions through the strategic combination of advanced diagnostics, artificial intelligence, and sustained behavioral support.

Click here for the original news story.